Quote:
Originally Posted by photon
Probably, but I doubt that's their distribution plan. I wonder if it's just "whoever ordered first gets it first" or if they proportionally give doses to everyone they've got contracts with as they're produced.
|
It'll be a mix between the two. Governments like the US that invested in the infrastructure in return for owning doses will get preferential treatment, but it's certainly not a case of whoever ordered it first gets the first doses. The EU just signed a deal with Pfizer a little over a week ago, but it sounds like they're expecting doses before Canada who signed on in early August. BioNTech has said they're largely trying to ship out doses to countries in proportion to their population, but obviously logistics are going to play into that a bit. The good news for Canada on that front is that Pfizer never took US government money to develop or test the vaccine, so they're allowed to sell to whomever they want. And it sounds like about about 50% of US production, in the first few months at least, is destined for non-US markets.
With Moderna, the US bankrolled part of the manufacturing and paid for some of their trials, so they essentially own the first 100M doses made in the US. Other countries will get their doses from Swiss production, which is supposed to be about 30M a month. Not many countries other than Canada have deals with Moderna right now (just the US, Japan, and then small orders from Israel, the UK, and Switzerland), so hopefully Canada gets a good supply from that.
Here's a tracker with currently publicly released vaccine orders:
https://launchandscalefaster.org/sit...%20Company.png